Gene: SMIM47
Official Full Name: small integral membrane protein 47provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13897 | SMIM47 Knockout cell line (HeLa) | Human | SMIM47 | 1:3~1:6 | Negative | Online Inquiry |
KO13898 | SMIM47 Knockout cell line (HCT 116) | Human | SMIM47 | 1:2~1:4 | Negative | Online Inquiry |
KO13899 | SMIM47 Knockout cell line (HEK293) | Human | SMIM47 | 1:3~1:6 | Negative | Online Inquiry |
KO13900 | SMIM47 Knockout cell line (A549) | Human | SMIM47 | 1:3~1:4 | Negative | Online Inquiry |
SMIM47 Gene Knockout Cell Lines are specialized cellular models engineered for the comprehensive study of the SMIM47 gene's function and its implications in various biological processes. By employing advanced CRISPR-Cas9 gene editing techniques, these cell lines exhibit a complete knockout of the SMIM47 gene, enabling researchers to investigate its role in cellular mechanisms such as gene regulation, cell signaling, and metabolic pathways.
The primary function of SMIM47 Gene Knockout Cell Lines is to serve as a controlled environment for analyzing the phenotypic changes resulting from the absence of the SMIM47 gene. Researchers can gain insights into the gene’s contributions to diseases, cellular stress responses, and interactions with other genes, which are crucial for therapeutic development. The juxtaposition of knockout versus wild-type cell lines provides a powerful framework for understanding the gene's role in pathophysiology and drug response.
The scientific importance of these cell lines extends to both research and clinical applications. They can be utilized in the identification of potential biomarkers for diseases associated with SMIM47, such as certain metabolic disorders or cancer types. Moreover, they provide a platform for high-throughput drug screening, allowing for the discovery of novel therapeutic agents targeting pathways influenced by SMIM47.
What sets our SMIM47 Gene Knockout Cell Lines apart from traditional models or competitors is their robust validation and the specificity of the knockout achieved, facilitating reproducible and reliable results. Our cell lines are designed with the highest quality standards, ensuring consistency across experiments, which is critical for obtaining credible data.
For researchers and clinicians focused on genetic research, drug development, and functional genomics, the value of these cell lines lies in their ability to expedite research timelines and enhance the understanding of the SMIM47 gene's biological roles. With a strong commitment to innovation and quality, our company brings expertise in cellular biology and advanced genetic engineering to deliver products that empower groundbreaking discoveries in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.